Ensayos Clínicos

Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment

Pharmacokinetics of LCQ908 in Patients With Renal Impairment

A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome

Efficacy of LCQ908 on Cardiovascular Risk

A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia

Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.

Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients

A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)